Blog

Francesco Cortiula: What evidences for the treatment of patients with stage III NSCLC excluded from trials?

Photo taken from Francesco Cortiula/X

Jul 7, 2024, 15:44

Francesco Cortiula: What evidences for the treatment of patients with stage III NSCLC excluded from trials?

Francesco Cortiula, Medical Oncologist at University Hospital of Udine, made the following post on X:

“What evidences for the treatment of patients with stage III NSCLC excluded from trials?

Auto-immune disorders
HIV
CV and lung comorbidities

Do we need novel approaches?

Check out our review!

Lizza Hendriks, Jarushka Naidoo, Martina Bortolot.”

Source: Francesco Cortiula/X

auto-immune disorders cancer cardiovascular comorbidities Francesco Cortiula HIV Jarushka Naidoo Lizza Hendriks lung comorbidities Martina Bortolot non small cell lung cancer novel approaches OncoDaily Oncology oncology research stage III NSCLC treatment evidence University Hospital of Udine

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Special Coverage